Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

BTOG 2018 | Lung cancer screening challenge: how do we prevent unnecessary biopsies?

One issue with lung cancer screening is that nodules, which may or may not be malignant, can be detected, leading to unnecessary biopsies and stress for patients who do not have lung cancer. In this interview, Robert Rintoul, PhD, FRCP, of the Cancer Research UK Cambridge Institute, Cambridge, UK, discusses the issue. Dr Rintoul highlights the need for non-invasive assays to determine the probability of nodules being cancerous, referencing his group’s work investigating exhaled breath signatures, as well as blood samples to detect ctDNA. This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.